Diflunisal: Clinical Trials

5 trials of Diflunisal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 2 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1
Phase 31Completed 1
Phase 41Terminated 1

Follow Diflunisal: new trials by email Literature Review of Diflunisal trials Research Report on Diflunisal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects Diflunisal on the Levels of BMS-986165 in Healthy Participants
BMS-986165, diflunisal - Healthy Participants
Phase 1CompletedBristol-Myers Squibb482019-10-012020-08-05
Pilot Study of Diflunisal in HIV-infected Adults
Diflunisal - HIV Infection
Phase 4TerminatedUniversity of British Columbia82013-03-012017-10-27
The Effect of Diflunisal on Familial Transthyretin Amyloidosis
Diflunisal - Amyloidosis
CompletedUmeå University552011-08-012015-08-24
Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes
bezafibrate + diflunisal, bezafibrate + placebo - Type 2 Diabetes
Phase 2CompletedZalicus1502007-07-012009-05-13
The Effect of Diflunisal on Familial Amyloidosis
diflunisal, placebo - Familial Amyloid Polyneuropathy, Familial Amyloidosis
Phase 2 / Phase 3CompletedBoston University1302006-02-012017-03-17

Conditions studied

Amyloidosis (2)  ·  Amyloid Neuropathies, Familial (1)  ·  Amyloidosis, Familial (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  HIV Infections (1)  ·  Peripheral Nervous System Diseases (1)

Sponsors

Boston University (1)  ·  Bristol-Myers Squibb (1)  ·  Umeå University (1)  ·  University of British Columbia (1)  ·  Zalicus (1)

Countries

Canada (2)  ·  Sweden (2)  ·  United States (2)  ·  Italy (1)  ·  Japan (1)  ·  United Kingdom (1)

Top investigators

John L. Berk, MD (1)  ·  Julio Montaner, MD (1)  ·  Ole B Suhr, MD PhD (1)  ·  Tim Zmijowskyj, MD (1)

Results publications

PMID 24368466

NIH funding

R01NS051306 (1)